Xeris Biopharma Holdings, Inc. (XERS)

CIK 1867096 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Xeris Biopharma Holdings, Inc..

Recent SEC filings

FiledFormAccession number
Sep 9, 20268-K0001867096-26-000077
Sep 1, 202640002031695-26-000011
Sep 1, 202640001652410-26-000018
Sep 1, 202640001875714-26-000012
Aug 21, 202640001867096-26-000069
Aug 21, 202640001867096-26-000073
Aug 12, 202640001875714-26-000009
Aug 12, 20261440001950047-26-008033
Aug 6, 202610-Q0001867096-26-000065
Aug 6, 20268-K0001867096-26-000063
Aug 4, 202640001652410-26-000016
Aug 4, 202640001867096-26-000059
Jul 31, 2026SCHEDULE 13G0002100119-26-001430
Jul 17, 20268-K0001867096-26-000055
Jul 7, 202640001875714-26-000007
Jul 7, 20261440001950047-26-006941
Jul 6, 20261440001950047-26-006884
Jul 2, 202640001652410-26-000014
Jul 2, 202640001741850-26-000002
Jul 2, 202640002031695-26-000008
Jul 2, 202630001867096-26-000051
Jul 1, 20261440001950047-26-006705
Jul 1, 20261440001950047-26-006741
Jun 30, 20268-K0001867096-26-000048
Jun 11, 20268-K0001867096-26-000045